232 related articles for article (PubMed ID: 22208657)
1. Primary Sjögren's syndrome and the type I interferon system.
Nordmark G; Eloranta ML; Ronnblom L
Curr Pharm Biotechnol; 2012 Aug; 13(10):2054-62. PubMed ID: 22208657
[TBL] [Abstract][Full Text] [Related]
2. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
[TBL] [Abstract][Full Text] [Related]
3. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
4. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
Front Immunol; 2019; 10():2096. PubMed ID: 31552042
[TBL] [Abstract][Full Text] [Related]
6. Type I interferons in Sjögren's syndrome.
Yao Y; Liu Z; Jallal B; Shen N; Rönnblom L
Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
Nordmark G; Alm GV; Rönnblom L
Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
[TBL] [Abstract][Full Text] [Related]
8. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.
Gottenberg JE; Cagnard N; Lucchesi C; Letourneur F; Mistou S; Lazure T; Jacques S; Ba N; Ittah M; Lepajolec C; Labetoulle M; Ardizzone M; Sibilia J; Fournier C; Chiocchia G; Mariette X
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2770-5. PubMed ID: 16477017
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
[TBL] [Abstract][Full Text] [Related]
10. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
[TBL] [Abstract][Full Text] [Related]
11. Activation of the type I interferon pathway in primary Sjogren's syndrome.
Mavragani CP; Crow MK
J Autoimmun; 2010 Nov; 35(3):225-31. PubMed ID: 20674271
[TBL] [Abstract][Full Text] [Related]
12. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
[TBL] [Abstract][Full Text] [Related]
14. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
16. Type I IFN signature in primary Sjögren's syndrome patients.
Brkic Z; Versnel MA
Expert Rev Clin Immunol; 2014 Apr; 10(4):457-67. PubMed ID: 24450331
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
Imgenberg-Kreuz J; Sandling JK; Almlöf JC; Nordlund J; Signér L; Norheim KB; Omdal R; Rönnblom L; Eloranta ML; Syvänen AC; Nordmark G
Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
[TBL] [Abstract][Full Text] [Related]
18. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update.
Vakaloglou KM; Mavragani CP
Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509
[TBL] [Abstract][Full Text] [Related]
19. Aspects of innate immunity in Sjögren's syndrome.
Low HZ; Witte T
Arthritis Res Ther; 2011 May; 13(3):218. PubMed ID: 21635716
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands.
Alunno A; Caneparo V; Carubbi F; Bistoni O; Caterbi S; Gariglio M; Bartoloni E; Landolfo S; Gerli R
Reumatismo; 2015 Dec; 67(3):85-90. PubMed ID: 26876186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
